Latest News about LLY
Recent news which mentions LLY
Viking Obesity Pill Faces Steep Climb Against Lilly's Tirzepatide, Analyst Calls Downtrend Reaction 'Extreme'
August 19, 2025
From Benzinga
Why Novo Nordisk Stock Popped Today
August 19, 2025
From Motley Fool
From Benzinga
From Motley Fool
Stock Market Today: S&P 500 Slips, Dow Futures Rise—Intel, Palo Alto, Home Depot In Focus
August 19, 2025
From Benzinga
Eli Lilly Considering Viking Therapeutics Acquisition? Expert Says 'They're Setting Up For Something BIG' As LLY Issues 40-Year Bond
August 19, 2025
From Benzinga
GoodRx Holdings Surges 5% After Hours on Novo Nordisk Partnership for $499 Monthly Ozempic, Wegovy Access
August 19, 2025
From Benzinga
Ozempic And Wegovy Now Available Through GoodRx At Reduced Self-Pay Price, Stock Skyrockets
August 18, 2025
From Benzinga
Wall Street Is Now Dumping Its Junk On The Regular Investor
August 17, 2025
From TalkMarkets
1 Beaten-Down Stock That Could Soar by the End of the Year
August 17, 2025
From Motley Fool
This Healthcare Stock's Bad News Could Create a $10 Billion Opportunity for Competitors
August 17, 2025
From Motley Fool
3 Fantastic Growth Stocks to Buy in August
August 17, 2025
From Motley Fool
From Benzinga
From Motley Fool
A Look Into Eli Lilly Inc's Price Over Earnings
August 15, 2025
From Benzinga
From Benzinga
UnitedHealth's Best Day Since 2008, Intel's Best Weekly Gain In Decades: What's Moving Markets Friday?
August 15, 2025
From Benzinga
Viking Global Dumps UnitedHealth, Loads Up On Disney, McDonald's, JPMorgan, AMD In Q2 Shake-Up
August 15, 2025
From Benzinga
Guidance Watch: 2 Companies Bullishly Raising Forecasts
August 15, 2025
From TalkMarkets
Eli Lilly Strikes $1.3 Billion Deal With Superluminal To Develop AI-Driven Obesity Drugs
August 15, 2025
From Benzinga
Eli Lilly & Co.: Deep Pullback Near 52‑Week Low Tests Strong Fundamentals And Bullish Analyst Targets
August 14, 2025
Tickers
LLY
From TalkMarkets
From Benzinga
Why Eli Lilly Stock Popped Today
August 13, 2025
From Motley Fool
Weighing The Costs: Obesity Drug Users Make Financial Sacrifices As Coverage Tightens
August 13, 2025
From Benzinga
Viking's Oral Obesity Drug Poised To Gain Ground After Eli Lilly's Orforglipron Setback: Analyst
August 13, 2025
From Benzinga
How Novo Nordisk's Weight-Loss Drug Could Unlock A Better Future For Biogen's Alzheimer's Treatment
August 13, 2025
From Benzinga
From Benzinga
From Benzinga
The 3 Things That Matter for Viking Therapeutics Now
August 13, 2025
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.